Shanghai Pharmaceuticals Holding Co.,Ltd — Investor Relations & Filings
Shanghai Pharmaceuticals Holding Co., Ltd. is a vertically integrated pharmaceutical group that operates across the entire industry value chain, including research and development, manufacturing, distribution, and retail. The company focuses on a diverse portfolio of products, including chemical drugs, biological products, modern Chinese medicine, and healthcare products. Its research initiatives prioritize innovative therapies in oncology, immunology, and cardiovascular health. SPH maintains an extensive commercial network, providing comprehensive supply chain solutions and logistics services to hospitals and retail pharmacies. The company distinguishes itself through its large-scale manufacturing capabilities and a robust distribution infrastructure that ensures broad market access. By integrating industrial production with a sophisticated commercial platform, the company aims to deliver high-quality medical solutions and optimize healthcare delivery systems.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 上海医药集团股份有限公司关于利伐沙班片获得泰国药品注册证书的公告 | 2026-05-07 | Chinese | |
| 上海医药集团股份有限公司关于持股5%以上股东权益变动触及1%刻度的提示性公告 | 2026-05-07 | Chinese | |
| 上海医药集团股份有限公司2025年度可持续发展报告暨环境、社会及治理（ESG）报告摘要 | 2026-03-30 | Chinese | |
| 国浩律师（上海）事务所关于上海医药注销部分股票期权相关事宜之法律意见书 | 2026-03-30 | Chinese | |
| 上海医药集团股份有限公司对2025年度会计师事务所履职情况的评估报告 | 2026-03-30 | Chinese | |
| 上海医药集团股份有限公司2026年度日常关联交易公告 | 2026-03-30 | Chinese |
Browse filings by year
28 years- 2026 48 filings
- 2025 178 filings
- 2024 141 filings
- 2023 161 filings
- 2022 144 filings
- 2021 141 filings
- 2020 105 filings
- 2019 156 filings
- 2018 97 filings
- 2017 85 filings
- 2016 117 filings
- 2015 70 filings
- 2014 60 filings
- 2013 66 filings
- 2012 49 filings
- 2011 67 filings
- 2010 78 filings
- 2009 59 filings
- 2008 43 filings
- 2007 50 filings
- 2006 53 filings
- 2005 33 filings
- 2004 27 filings
- 2003 26 filings
- 2002 31 filings
- 2001 12 filings
- 1998 1 filing
- 1994 2 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 44265335 | 上海医药集团股份有限公司关于利伐沙班片获得泰国药品注册证书的公告 | 2026-05-07 | Chinese | ||
| 44265320 | 上海医药集团股份有限公司关于持股5%以上股东权益变动触及1%刻度的提示性公告 | 2026-05-07 | Chinese | ||
| 41711931 | 上海医药集团股份有限公司2025年度可持续发展报告暨环境、社会及治理（ESG）报告摘要 | 2026-03-30 | Chinese | ||
| 41711924 | 国浩律师（上海）事务所关于上海医药注销部分股票期权相关事宜之法律意见书 | 2026-03-30 | Chinese | ||
| 41711919 | 上海医药集团股份有限公司对2025年度会计师事务所履职情况的评估报告 | 2026-03-30 | Chinese | ||
| 41711917 | 上海医药集团股份有限公司2026年度日常关联交易公告 | 2026-03-30 | Chinese | ||
| 41711910 | 上海医药集团股份有限公司2025年度独立董事述职报告-王忠 | 2026-03-30 | Chinese | ||
| 41711904 | 上海医药集团股份有限公司2025年度内部控制评价报告 | 2026-03-30 | Chinese | ||
| 41711900 | 上海医药集团股份有限公司关于注销公司2019年A股股票期权激励计划预留股票期权第三个行权期已到期未行权的股票期权的公告 | 2026-03-30 | Chinese | ||
| 41711893 | 上海医药集团股份有限公司第八届董事会第二十九次会议决议公告 | 2026-03-30 | Chinese | ||
| 41711890 | 上海医药集团股份有限公司董事会审计委员会2025年度履职报告 | 2026-03-30 | Chinese | ||
| 41711881 | 上海医药集团股份有限公司关于拟发行债务融资产品的公告 | 2026-03-30 | Chinese | ||
| 41711875 | 上海医药集团股份有限公司关于2026年度开展金融衍生品业务的公告 | 2026-03-30 | Chinese | ||
| 41711865 | 上海医药集团股份有限公司2025年度独立董事述职报告-万钧 | 2026-03-30 | Chinese | ||
| 41711856 | 上海医药集团股份有限公司2025年年度报告 | 2026-03-30 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Shanghai Pharmaceuticals Holding Co.,Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/57260/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=57260 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=57260 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=57260 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 57260}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Shanghai Pharmaceuticals Holding Co.,Ltd (id: 57260)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.